All In Biotech

NDA 021074 · Solventum

Avagard

Alcohol, Chlorhexidine Gluconate · Topical

Last checked: Nov 20, 2026Latest source record: Sep 6, 2017 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2001

Jun 7, 2001

Approved uses

1

Original approval plus efficacy supplements

Registered trials

6,382

1,281 Phase 3, 471 recruiting

FAERS reports

5

4 serious, 0 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Apr 22, 2026.

Uses surgical hand antiseptic: significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care healthcare personnel hand antiseptic: hand rub to help reduce bacteria that potentially can cause disease recommended for repeated use

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

1 products under this application
  • AVAGARD · ALCOHOL 61%; CHLORHEXIDINE GLUCONATE 1% · SOLUTION, TOPICAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Alcohol" as an intervention, any sponsor and status, largest first.

All 6,382 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • rash2
  • rash pruritic2
  • burns second degree1
  • burns third degree1
  • eye irritation1
  • urticaria1

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20131
20151
20172
20201

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 18,898 on PubMed

Sponsor: Solventum

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.